Tag: Cancer: Lung
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
No difference in overall survival seen with nivolumab plus ipilimumab, nivolumab alone for advanced, chemotherapy-pretreated disease
ASCO: Sotorasib Targets KRAS p.G12C-Mutated NSCLC
Objective response seen in 37.1 percent of patients with previously treated KRAS p.G12C-mutated non-small cell lung cancer
Low-Dose CT Screening for Lung Cancer Can Also ID Aortic Stenosis
Any degree of aortic valve calcification was identified in 13.1 percent of participants; 0.5 percent had at least moderate AS
AI Algorithm Helps Evaluate Pulmonary Nodules Detected on Screening CT
Deep learning algorithm could aid malignancy risk estimation of pulmonary nodules detected on low-dose screening CT
USPSTF Expands Eligibility for Annual Lung Cancer Screening
Adults aged 50 to 80 years with 20 pack-year smoking history who currently smoke or quit within last 15 years should be screened with low-dose CT
Model Can Aid Assessment of Multiple Pulmonary Nodules
Validated machine-based learning model performs better than surgeons, radiologists, CADx for predicting malignancy
FDA Approves Therapy to Protect Bone Marrow Cells From Effects of Chemotherapy
Cosela reduces the frequency of bone marrow suppression caused by chemotherapy for extensive-stage small cell lung cancer
Residential Segregation May Worsen NSCLC Outcomes for Black Patients
Blacks more likely to present at advanced stage, less likely to receive surgery, have higher mortality at higher residential segregation levels
Disparities in Lung Cancer Screening Eligibility Still Exist
Findings seen despite the U.S. Preventive Services Task Force revised eligibility criteria
Pandemic Has Disrupted Lung Cancer Screenings
Once operations resumed, decrease seen in new patients screened, proportion of suspicious nodules increased
